REPAGLINIDE MEVON TABLETS 1 MG
Product details
Registration number: SIN16375P
Classification: Prescription Only
Active ingredients: Repaglinide
Strength: 1.0 mg
Dosage form: TABLET
Route: ORAL
Registrant: NOVEM PHARMA PRIVATE LIMITED
ATC code: A10BX02
HSA approval date: 12 November 2021
Manufacturer(s): Pharmathen S.A.
Manufacturing country/countries: GREECE
What are the HSA registration number and classification for REPAGLINIDE MEVON TABLETS 1 MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16375P
Classification: Prescription Only
What active ingredients and strength are recorded for REPAGLINIDE MEVON TABLETS 1 MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Repaglinide
Strength: 1.0 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for REPAGLINIDE MEVON TABLETS 1 MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET
Route: ORAL
Who is the recorded registrant for REPAGLINIDE MEVON TABLETS 1 MG?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVEM PHARMA PRIVATE LIMITED
Which manufacturers and countries are listed for REPAGLINIDE MEVON TABLETS 1 MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Pharmathen S.A.
Manufacturing country/countries: GREECE
Where can I look up REPAGLINIDE MEVON TABLETS 1 MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16375P or the exact product name REPAGLINIDE MEVON TABLETS 1 MG. The general register link does not preselect this product.
What are the source dates for this REPAGLINIDE MEVON TABLETS 1 MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this REPAGLINIDE MEVON TABLETS 1 MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16375P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)